Charlotte's Web Holdings (CWBHF) Shares Outstanding (2020 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Shares Outstanding (Entity) of $159.7 million for Q1 2026, up 1.06% year-over-year from $158.0 million in Q1 2025, and little changed quarter-over-quarter from $159.4 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Shares Outstanding (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Shares Outstanding (Entity) for 7 consecutive years, with $159.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1.06% year-over-year to $159.7 million; the TTM figure through Mar 2026 stood at $159.7 million (up 1.06% YoY), while the FY2025 annual figure was $159.4 million, up 0.89% from the prior year.
- Shares Outstanding (Entity) held at $159.7 million in Q1 2026 per CWBHF's latest filing, from $159.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $159.7 million in Q1 2026 and bottomed at $145.1 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $154.5 million across 5 years, with a median of $157.2 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) advanced 15.22% — and 2025, when it rose 0.5%.
- Charlotte's Web Holdings' Shares Outstanding (Entity) stood at $152.1 million in 2022, then climbed by 1.44% to $154.3 million in 2023, then grew by 2.38% to $158.0 million in 2024, then grew by 0.89% to $159.4 million in 2025, then grew by 0.17% to $159.7 million in 2026.
- Business Quant data shows CWBHF's Shares Outstanding (Entity) at $159.7 million in Q1 2026, $159.4 million in Q4 2025, and $159.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 832.44 Mn |
| 10 | Charlotte's Web Holdings | 63.18 Mn | 49.19 Mn | 5.16 Mn | 198.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 198.67 Mn |
| Mar 31, 2026 | 159.67 Mn |
| Dec 31, 2025 | 158.79 Mn |
| Sep 30, 2025 | 159.11 Mn |
| Jun 30, 2025 | 158.61 Mn |
| Mar 31, 2025 | 158.01 Mn |
| Dec 31, 2024 | 157.56 Mn |
| Sep 30, 2024 | 157.50 Mn |
| Jun 30, 2024 | 157.23 Mn |
| Mar 31, 2024 | 156.04 Mn |
| Dec 31, 2023 | 152.94 Mn |
| Sep 30, 2023 | 153.09 Mn |
| Jun 30, 2023 | 152.48 Mn |
| Mar 31, 2023 | 152.31 Mn |
| Dec 31, 2022 | 146.63 Mn |
| Sep 30, 2022 | 145.33 Mn |
| Jun 30, 2022 | 145.17 Mn |
| Mar 31, 2022 | 144.99 Mn |
| Dec 31, 2021 | 140.77 Mn |
| Sep 30, 2021 | 140.52 Mn |